CoChat

The effects of fluoxetine combined with nicotine inhalers in smoking cessation‐a randomized trial

Blondal, Thorsteinn, Gudmundsson, Larus J., Tomasson, Kristinn, Jonsdottir, Dagmar, Hilmarsdottir, Holmfridur, Kristjansson, Fjalar, Nilsson, Fredrik, Bjornsdottir, Unnur Steina · 1999 · Addiction
Cited by 87

The DOI matches its Crossref record.

Abstract

Aims. Nicotine replacement therapy (NRT) is an established aid in stopping smoking, while the role of antidepressants remains uncertain. Antidepressants added to NRT might improve abstinence rates. Our aim was to determine the efficacy of nicotine inhaler and fluoxetine vs. nicotine inhaler and placebo in attempts to quit smoking. Design. A randomized, double‐blind, placebo‐controlled trial. Setting. A smoker's cessation clinic. Participants. One hundred volunteers smoking 10 cigarettes/day or more. Interventions. Subjects were instructed to start taking a daily dose of 10 mg of fluoxetine or placebo 16 days before stopping smoking, then 20 mg 10 days before quitting, continuing for up to at least 3 months. Subjects were instructed to use 6‐12 units per day of nicotine inhalers after stopping smoking for up to 6 months. Measurements. Continuous abstinence rates recorded at various time points up to 12 months from the quit date. Findings. The sustained abstinence rate for the inhaler‐fluoxetine group was 54%, 40%, 29% and 21% after 1.5, 3, 6 and 12 months, respectively, compared to 48%, 40%, 32% and 23% for the inhaler‐placebo group. The differences were not significant at any time point. Abstinence up to 3 months was more likely in older smokers, those with a lower Beck Depression Inventory Score (BDI), lower Fagerstrom Test of Nicotine Dependence (FTND) score and no history of alcoholism. Fluoxetine appeared to increase abstinence rates among high BDI smokers compared to high BDI smokers assigned placebo. Serum levels of nicotine during treatment in the inhaler‐fluoxetine group were lower than in the inhaler‐placebo group so that fluoxetine may have reduced inhaler use through a common site of action. Conclusions. We found no evidence that fluoxetine treatment when used as an adjunct to NRT in unselected smokers is effective, but there may be an advantage to using it in depressed smokers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1360-0443.1999.94710076.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 87

Metadata

Authors
Blondal, T., Gudmundsson, L. J., Tomasson, K., Jonsdottir, D., Hilmarsdottir, H., Kristjansson, F., Nilsson, F., & Bjornsdottir, U. S.
Venue
Addiction
Publisher
Wiley
Published
1999-07
Volume
94
Issue
7
Pages
1007-1015
ISSN
  • 0965-2140 (ISSN-L)
  • 1360-0443
OpenAlex
W1974004281
Cited by
87
References
0
FWCI
1.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effects of fluoxetine combined with nicotine inhalers in smoking cessation‐a randomized trial. https://app.cochat.ai/papers/10.1046/j.1360-0443.1999.94710076.x
The paper
Blondal, T., Gudmundsson, L. J., Tomasson, K., Jonsdottir, D., Hilmarsdottir, H., Kristjansson, F., Nilsson, F., & Bjornsdottir, U. S. (1999). The effects of fluoxetine combined with nicotine inhalers in smoking cessation‐a randomized trial. Addiction. https://doi.org/10.1046/j.1360-0443.1999.94710076.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.